Your CRO’s Assignment Strategy for CRAs Matters!
Monitoring the progress of clinical research is fundamental to obtaining successful outcomes because it ensures that constraints to success are…
Lessons Learned Moving Forward – Audit Readiness & Remote Close-Out Visits
The COVID-19 pandemic has required the clinical research industry to find new and innovative ways to monitor investigative sites. Although…
Prime Location for Global Clinical Studies?
Canada is considered one of the most attractive places to live in the world, with a high quality of life,…
Why Not Canada for Your Phase 3 Global Trial Expansion?
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Diversity in Clinical Trial Participants: Canada Holds Promise
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
Let Canada Contribute to Your Basket Trial Success
With the emergence of basket trials in the early-phase oncology setting, clinical research teams are faced with challenges of enrollment…
The Canadian Landscape for Childhood Cancer Research
Pediatric Hematology Oncology is a relatively recent area of study. Only in the past 50 years have substantial advances taken…
2020 a Year Like No Other: What it Takes to Keep Ahead of Rapid Change
This time last year none of us imagined we were about to go through a year like no other, and…
Overcome Oncology Clinical Trial Obstacles – 2020 Real World Evidence for 2021 and Beyond
Study start-up is one the most time-intensive areas within clinical drug development, accounting for two thirds or more of total…
Continued Importance of CRAs Supporting Role for Patient Centric Trials
The COVID-19 world-wide pandemic has forced the clinical trial industry to make rapid changes in order to continue protecting participant…